Skip to main content
Caplight Logo









OcuCell Inc.

OcuCell Inc.

Private
Portland, OregonHealthcare & Life Scienceshttps://ocucell.bio

Last Round

Seed

Sep 26, 2023

Company Overview

OcuCell Inc. operates in Healthcare & Life Sciences and is based in Portland, Oregon. Its latest recorded funding round was a Seed round in September 2023.

OcuCell Inc. is a biotechnology company that develops regenerative cell therapies for the treatment of corneal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

OcuCell Inc. Comparables

Compare OcuCell Inc. with similar companies based on industry and business-model similarity.

OcuCell Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
StemSight
88%
Cellusion Inc.
80%
Visionary BioMed
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

OcuCell Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 26, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

OcuCell Inc. Investors

Notable investors and investment history

OcuCell Inc. investors
InvestorRounds
Johns Hopkins Technology VenturesSeed
Eye Bank Association of AmericaSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 26, 2023

    Secured seed funding from multiple investors including Johns Hopkins Technology Ventures.

Book a demo to see all signals

For institutional investors. Book with your work email.

OcuCell Inc. Filings

Explore SEC and related filing metadata, where available.

OcuCell Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about OcuCell Inc.'s valuation, stock price, and market status.

Is OcuCell Inc. a public or private company?

OcuCell Inc. is a private company.

What is the current stock price of OcuCell Inc.?

OcuCell Inc. is a private company, so its shares have no public market price. Caplight tracks OcuCell Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is OcuCell Inc. worth (valuation)?

Valuation information for OcuCell Inc. is not publicly available.

Can I buy OcuCell Inc. stock?

OcuCell Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was OcuCell Inc.'s last funding round?

OcuCell Inc.'s most recent funding round was Seed on September 26, 2023.

Who are the main investors in OcuCell Inc.?

Key investors in OcuCell Inc. include Johns Hopkins Technology Ventures, Eye Bank Association of America.

Will OcuCell Inc. IPO soon?

No public IPO plans have been announced for OcuCell Inc..

How can I track OcuCell Inc. secondary market activity?

Caplight tracks bids, offers, and trades in OcuCell Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersPortland, Oregon
Year Founded2022
Last FundingSep 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?